{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T11:00:41Z","timestamp":1756897241769},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,20]]},"DOI":"10.7759\/cureus.60696","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:59:06Z","timestamp":1716231546000},"source":"Crossref","is-referenced-by-count":2,"title":["Intra-arterial Chemotherapy in Patients With Metastatic or Locally Aggressive Pancreatic Adenocarcinoma: A Scoping Review"],"prefix":"10.7759","author":[{"given":"Mahi","family":"Basra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemangi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Biglione","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi JD","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. Lancet. 2020, 395:2008-20. 10.1016\/S0140-6736(20)30974-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003098","article-title":"Gemcitabine-based regional intra-arterial infusion chemotherapy in patients with advanced pancreatic adenocarcinoma","volume":"95","author":"Liu X","year":"2016","unstructured":"Liu X, Yang X, Zhou G, Chen Y, Li C, Wang X. Gemcitabine-based regional intra-arterial infusion chemotherapy in patients with advanced pancreatic adenocarcinoma. Medicine. 2016, 95:e3098. 10.1097\/MD.0000000000003098","journal-title":"Medicine"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1089\/pancan.2017.0011","article-title":"Safety study of targeted and localized intra-arterial delivery of gemcitabine in patients with locally advanced pancreatic adenocarcinoma","volume":"3","author":"Rosemurgy AS","year":"2017","unstructured":"Rosemurgy AS, Ross SB, Vitulli PL, Malek R, Li J, Agah R. Safety study of targeted and localized intra-arterial delivery of gemcitabine in patients with locally advanced pancreatic adenocarcinoma. J Pancreat Cancer. 2017, 3:58-65. 10.1089\/pancan.2017.0011","journal-title":"J Pancreat Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000163360.40357.f1","article-title":"A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma","volume":"29","author":"Adsay NV","year":"2005","unstructured":"Adsay NV, Basturk O, Bonnett M, et al.. A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma. Am J Surg Pathol. 2005, 29:724-33. 10.1097\/01.pas.0000163360.40357.f1","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000354992","article-title":"Pancreatic cancer: current options for diagnosis, staging and therapeutic management","volume":"1","author":"Hartwig W","year":"2013","unstructured":"Hartwig W, B\u00fcchler MW. Pancreatic cancer: current options for diagnosis, staging and therapeutic management. Gastrointest Tumors. 2013, 1:41-52. 10.1159\/000354992","journal-title":"Gastrointest Tumors"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040847","article-title":"Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Liu F","year":"2012","unstructured":"Liu F, Tang Y, Sun J, et al.. Regional intra-arterial vs. systemic chemotherapy for advanced pancreatic cancer: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2012, 7:e40847. 10.1371\/journal.pone.0040847","journal-title":"PLoS One"},{"key":"ref7","article-title":"Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience","volume":"54","author":"Milandri C","year":"2007","unstructured":"Milandri C, Calzolari F, Passardi A, Tison C, Giampalma E, Cecconetto L, Golfieri R. Intra-arterial chemotherapy of advanced pancreatic cancer: a single center experience. Hepatogastroenterology. 2007, 54:2373-7.","journal-title":"Hepatogastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0b013e31812e9672","article-title":"Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy","volume":"36","author":"Mambrini A","year":"2008","unstructured":"Mambrini A, Bassi C, Pacetti P, et al.. Prognostic factors in patients with advanced pancreatic adenocarcinoma treated with intra-arterial chemotherapy. Pancreas. 2008, 36:56-60. 10.1097\/mpa.0b013e31812e9672","journal-title":"Pancreas"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14010220","article-title":"Arterial administration of DNA crosslinking agents with restraint of homologous recombination repair by intravenous low-dose gemcitabine is effective for locally advanced pancreatic cancer","volume":"14","author":"Mori H","year":"2022","unstructured":"Mori H, Tanoue S, Takaji R, Ueda S, Okahara M, Ueda SS. Arterial administration of DNA crosslinking agents with restraint of homologous recombination repair by intravenous low-dose gemcitabine is effective for locally advanced pancreatic cancer. Cancers (Basel). 2022, 14:220. 10.3390\/cancers14010220","journal-title":"Cancers (Basel)"},{"key":"ref10","article-title":"Gemcitabine-capecitabine plus intra-arterial epirubicin-cisplatin in pretreated pancreatic cancer patients: a phase I study","volume":"29","author":"Mambrini A","year":"2009","unstructured":"Mambrini A, Pacetti P, Del Freo A, et al.. Gemcitabine-capecitabine plus intra-arterial epirubicin-cisplatin in pretreated pancreatic cancer patients: a phase I study. Anticancer Res. 2009, 29:1547-9.","journal-title":"Anticancer Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16118","article-title":"First-line gemcitabine, nab-paclitaxel, and oxaliplatin chemotherapy with itraconazole in patients with metastatic pancreatic cancer: a single institution experience","volume":"42","author":"Sawasaki M","year":"2022","unstructured":"Sawasaki M, Tsubamoto H, Sugihara A, Ikuta S, Sakai Y, Osaki Y, Sonoda T. First-line gemcitabine, nab-paclitaxel, and oxaliplatin chemotherapy with itraconazole in patients with metastatic pancreatic cancer: a single institution experience. Anticancer Res. 2022, 42:6063-9. 10.21873\/anticanres.16118","journal-title":"Anticancer Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-014-0157-7","article-title":"Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study","volume":"33","author":"Beane JD","year":"2015","unstructured":"Beane JD, Griffin KF, Levy EB, et al.. Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally Advanced Pancreatic Cancer (RECLAP) study. Invest New Drugs. 2015, 33:109-18. 10.1007\/s10637-014-0157-7","journal-title":"Invest New Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/240156-intra-arterial-chemotherapy-in-patients-with-metastatic-or-locally-aggressive-pancreatic-adenocarcinoma-a-scoping-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T18:59:09Z","timestamp":1716231549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/240156-intra-arterial-chemotherapy-in-patients-with-metastatic-or-locally-aggressive-pancreatic-adenocarcinoma-a-scoping-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,20]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.60696","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,20]]}}}